The content on this site is intended for healthcare professionals only
Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal c...
Dr Marwan Fakih - City of Hope Comprehensive Cancer Center, Duarte, USA
23 Sep 2021
KRYSTAL-1: Adagrasib as monotherapy or combined with cetuximab in patients with ...
Dr Jared Weiss - UNC School of Medicine, Chapel Hill, USA
20 Sep 2021
Neoadjuvant chemotherapy with CapeOx alone vs standard chemoradiotherapy (CRT) w...
Dr Pei-Rong Ding - Sun Yat-sen University Cancer Center, Guangzhou, China
20 Sep 2021
OncoAlert and ecancer - ESMO 2021 Day 4
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
20 Sep 2021
FOLFOXIRI + bevacizumab + atezolizumab versus FOLFOXIRI + bevacizumab as first-l...
Dr Chiara Cremolini - University of Pisa, Pisa, Italy
18 Sep 2021
ESMO President: What to watch for at ESMO 2021
Prof Solange Peters - ESMO President
17 Sep 2021
Oesophageal and gastric cancers
Dr Mike Cusnir - Mount Sinai Medical Center, Florida, USA
28 Jul 2021
BEACON-CRC: first-line bevacizumab in colorectal cancer treatment
Prof Dan Aderka - Tel-Aviv University, Tel-Aviv, Israel
26 Jul 2021
OncoAlert and ecancer weekly round up for July 12- July 18, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
19 Jul 2021
Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600...
Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain
13 Jul 2021
OncoAlert and ecancer weekly round up for July 1- July 10, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
13 Jul 2021
Study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in...
Dr Zev Wainberg - University of California Los Angeles, California, USA
12 Jul 2021
